Question 1

Am I eligible to participate in this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer clinical trial (NCT00212615). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer clinical trial (NCT00212615). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of the combination treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer clinical trial (NCT00212615). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer clinical trial (NCT00212615). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests or procedures will I need to undergo while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer clinical trial (NCT00212615). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer clinical trial (NCT00212615). Contact the study team or your healthcare provider for specific answers.

What this study is about